Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Agile Therapeutics
Recent news which mentions Agile Therapeutics
Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
November 21, 2023
Tickers
AGRX
Tags
Partner Content
Market News
General
From
Benzinga
Agile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Group
September 27, 2023
Tickers
AGRX
Tags
News
Penny Stocks
Benzinga
From
Benzinga
Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter
August 16, 2023
Tickers
AGRX
Tags
Health Care
Benzinga
Penny Stocks
From
Benzinga
This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions Of Women Thanks To A Partnership With Afaxys
July 17, 2023
Tickers
AGRX
Tags
General
Partner Content
Market News
From
Benzinga
Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
July 14, 2023
Tickers
AGRX
Tags
News
Penny Stocks
Benzinga
From
Benzinga
Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden's Latest Executive Order Expanding Contraceptive Coverage
July 10, 2023
Tickers
AGRX
Tags
Penny Stocks
Benzinga
Agile Therapeutics
From
Benzinga
H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch
June 29, 2023
Tickers
AGRX
Tags
Analyst Ratings
Market News
Markets
From
Benzinga
This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023
June 26, 2023
Tickers
AGRX
Tags
News
Health Care
Benzinga
From
Benzinga
Agile Therapeutics – This Women's Healthcare Company's "Skinfusion" Technology Sets It Apart From Other Contraceptive Companies
June 16, 2023
Tickers
AGRX
Tags
Markets
Market News
General
From
Benzinga
Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 – What Is The Hype All About?
June 05, 2023
Tickers
AGRX
Tags
General
Market News
Partner Content
From
Benzinga
The Overturning of Roe v. Wade Has Changed The Landscape Of Birth Control; Smaller Companies Are Now An Integral Part Of Care
June 01, 2023
Tickers
AGRX
Tags
General
Market News
Partner Content
From
Benzinga
Agile Therapeutics: The CEO Of This Women's Healthcare Company That Recently Saw Revenue Growth Of 33% Speaks To Benzinga
May 03, 2023
Tickers
AGRX
Tags
AGRX
Agile Therapeutics
Benzinga
From
Benzinga
Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women
January 19, 2023
Tickers
AGRX
Tags
General
Market News
AGRX
From
Benzinga
This Biotech Company is Pursuing Positive Cash Flow In 2023
December 20, 2022
Tickers
AGRX
CVS
Tags
Market News
Partner Content
General
From
Benzinga
Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
November 14, 2022
Tickers
AGRX
DARE
HOLX
Tags
Health Care
Benzinga
Penny Stocks
From
Benzinga
Can This Company's Birth Control Patch Disrupt The Contraceptive Market?
October 25, 2022
Tickers
AGRX
DARE
Tags
Penny Stocks
Benzinga
Health Care
From
Benzinga
The Past Week's Notable Insider Buys Included Digitalbridge, Life Time, A SPAC And More
October 16, 2021
Tickers
AGRX
DBRG
LOKB
LTH
Tags
SAFE
News
Penny Stocks
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.